Free Trial

Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts

Beam Therapeutics logo
$17.44 -0.45 (-2.52%)
As of 04:00 PM Eastern

Beam Therapeutics Earnings Summary

Beam Therapeutics released Q1 2025 earnings on May 6, 2025, reporting an EPS of -$1.24, which missed analysts' consensus estimates of -$1.11 by $0.13. Quarterly revenue rose 1.4% year-over-year to $7.47 million, below analyst estimates of $14.69 million. With a trailing EPS of -$4.61, Beam Therapeutics' earnings are expected to grow next year, from ($4.57) to ($4.27) per share.

Upcoming Q2
Earnings Date
Aug. 5Before Market OpensEstimated
Consensus EPS
(May. 6)
-$1.11
Actual EPS
(May. 6)
-$1.24 Missed By -$0.13
Actual Revenue
(May. 6)
$7.47M

Q1 2025 Earnings Resources

BEAM Upcoming Earnings

Beam Therapeutics' next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules.

Get Beam Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Beam Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BEAM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BEAM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Beam Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20254-$1.20-$0.90-$1.05
Q2 20254-$1.06-$0.78-$0.98
Q3 20254-$1.08-$0.78-$0.96
Q4 20254-$1.12-$0.79-$0.96
FY 2025 16 -$4.46 -$3.25 -$3.95
Q1 20262-$0.94-$0.75-$0.85
Q2 20262-$0.98-$0.76-$0.87
Q3 20262-$0.99-$0.76-$0.88
Q4 20262-$1.00-$0.74-$0.87

Beam Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2025
(Estimated)
--------
5/6/2025Q1 2025-$1.11-$1.24 -$0.13-$1.24$14.69M$7.47M
2/25/2025Q4 2024-$1.25-$1.09+$0.16-$1.09$16.47M$30.00M
11/5/2024Q3 2024-$1.16-$1.17 -$0.01-$1.17$14.52M$14.30M
8/6/2024Q2 2024-$1.13-$1.11+$0.02-$1.11$14.18M$11.80M
5/7/2024Q1 2024-$1.42-$1.21+$0.21-$1.21$17.09M$7.40M
2/27/2024Q4 2023-$0.69$1.73+$2.42$1.73$34.16M$316.20M
11/8/2023Q3 2023-$1.33-$1.22+$0.11-$1.22$17.09M$17.20M
8/8/2023Q2 2023-$1.42-$1.08+$0.34-$1.08$17.32M$20.12M

Beam Therapeutics Earnings - Frequently Asked Questions

Beam Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on BEAM's earnings history.

In the previous quarter, Beam Therapeutics (NASDAQ:BEAM) missed the analysts' consensus estimate of ($1.11) by $0.13 with a reported earnings per share (EPS) of ($1.24). Learn more on analysts' earnings estimate vs. BEAM's actual earnings.

Beam Therapeutics (NASDAQ:BEAM) has a recorded annual revenue of $63.58 million.

Beam Therapeutics (NASDAQ:BEAM) has a recorded net income of -$132.53 million. BEAM has generated -$4.61 earnings per share over the last four quarters.

Beam Therapeutics's earnings are expected to grow from ($4.57) per share to ($4.27) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BEAM) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners